Surgery Partners (NASDAQ:SGRY) Sees Strong Trading Volume - Should You Buy?

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) shares saw strong trading volume on Wednesday . 1,672,223 shares were traded during trading, an increase of 8% from the previous session's volume of 1,548,301 shares.The stock last traded at $26.11 and had previously closed at $25.75.

Analysts Set New Price Targets

A number of research firms have commented on SGRY. UBS Group started coverage on shares of Surgery Partners in a research report on Monday, October 14th. They set a "buy" rating and a $38.00 price objective for the company. Cantor Fitzgerald reiterated an "overweight" rating and issued a $43.00 price target on shares of Surgery Partners in a research note on Friday, October 4th. Macquarie restated an "outperform" rating and set a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. Royal Bank of Canada decreased their price target on shares of Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 20th. Finally, KeyCorp started coverage on shares of Surgery Partners in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, Surgery Partners currently has an average rating of "Moderate Buy" and a consensus target price of $36.56.

Surgery Partners Price Performance

The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market cap of $3.26 billion, a price-to-earnings ratio of -53.38, a PEG ratio of 14.10 and a beta of 2.58. The business has a fifty day moving average price of $21.45 and a 200 day moving average price of $27.09.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same period in the previous year, the firm posted $0.15 EPS. The firm's revenue was up 14.3% compared to the same quarter last year. As a group, research analysts anticipate that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

Institutional Trading of Surgery Partners

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. KBC Group NV boosted its holdings in shares of Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after acquiring an additional 576 shares in the last quarter. Quarry LP raised its position in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company's stock valued at $73,000 after purchasing an additional 1,760 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. grew its holdings in shares of Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock worth $124,000 after purchasing an additional 3,379 shares during the last quarter. Creative Planning bought a new position in Surgery Partners in the 3rd quarter valued at approximately $258,000. Finally, Versor Investments LP acquired a new position in Surgery Partners in the 3rd quarter valued at approximately $271,000.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.